Clarivate Plc (NYSE:CLVT) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC cut its holdings in shares of Clarivate Plc (NYSE:CLVT - Free Report) by 11.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,565,739 shares of the company's stock after selling 1,679,043 shares during the period. Janus Henderson Group PLC owned about 1.77% of Clarivate worth $89,218,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CLVT. Price T Rowe Associates Inc. MD lifted its position in Clarivate by 5.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 247,446 shares of the company's stock valued at $1,839,000 after purchasing an additional 13,103 shares during the period. SG Americas Securities LLC acquired a new position in Clarivate during the second quarter valued at $1,410,000. Wealth Enhancement Advisory Services LLC raised its position in shares of Clarivate by 19.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 52,229 shares of the company's stock worth $297,000 after acquiring an additional 8,430 shares during the period. Cove Street Capital LLC acquired a new position in shares of Clarivate in the second quarter worth about $4,214,000. Finally, Raymond James & Associates raised its position in shares of Clarivate by 19.0% in the second quarter. Raymond James & Associates now owns 7,244,790 shares of the company's stock worth $41,223,000 after acquiring an additional 1,157,976 shares during the period. 85.72% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have weighed in on CLVT. Barclays decreased their price objective on shares of Clarivate from $5.00 to $4.00 and set an "underweight" rating for the company in a research report on Thursday, November 7th. Royal Bank of Canada cut their target price on shares of Clarivate from $7.00 to $6.00 and set a "sector perform" rating for the company in a research note on Thursday, November 7th. Finally, William Blair cut shares of Clarivate from an "outperform" rating to a "market perform" rating in a research note on Wednesday, November 6th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $7.25.

Insider Activity

In other news, insider Bar Veinstein sold 60,000 shares of the company's stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $7.00, for a total value of $420,000.00. Following the transaction, the insider now directly owns 916,583 shares in the company, valued at approximately $6,416,081. This represents a 6.14 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Michael J. Angelakis acquired 1,500,000 shares of the firm's stock in a transaction dated Wednesday, November 20th. The stock was bought at an average price of $5.11 per share, for a total transaction of $7,665,000.00. Following the completion of the acquisition, the director now owns 1,500,000 shares in the company, valued at approximately $7,665,000. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 22.77% of the company's stock.

Clarivate Price Performance

NYSE CLVT traded down $0.04 during trading hours on Thursday, hitting $5.71. 8,552,520 shares of the company's stock traded hands, compared to its average volume of 4,568,102. Clarivate Plc has a 52-week low of $4.25 and a 52-week high of $9.60. The company has a market capitalization of $4.06 billion, a PE ratio of -2.87 and a beta of 1.12. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.88 and a quick ratio of 0.88. The firm's 50-day moving average is $6.02 and its 200-day moving average is $6.09.

Clarivate (NYSE:CLVT - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.19 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.19. Clarivate had a negative net margin of 50.00% and a positive return on equity of 9.69%. The company had revenue of $622.20 million during the quarter, compared to analysts' expectations of $640.81 million. During the same quarter in the prior year, the company earned $0.18 EPS. Clarivate's revenue was down 3.9% compared to the same quarter last year. Equities analysts forecast that Clarivate Plc will post 0.63 EPS for the current fiscal year.

About Clarivate

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.